Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719158 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging Study of OTO-201 in AOMT
A Phase 2 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 2
- Development phase
- 95
- Enrollment target
NCT02719158 is a Phase 2 study that has completed, run by Otonomy. The registered enrollment target is 95 participants.
The verdict
NCT02719158, a Phase 2 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 95 participants
- Enrollment target
Study Summary
Dose Ranging Study of OTO-201 in AOMT
Interventions
- OTHER Sham
- DRUG 12 mg ciprofloxacin
- DRUG 6 mg ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02719158
The ClinicalTrials.gov registry entry for NCT02719158 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham is the first listed.
NCT02719158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02719158 about?
NCT02719158 is a clinical study titled "Dose Ranging Study of OTO-201 in AOMT". Dose Ranging Study of OTO-201 in AOMT
What is the current status of trial NCT02719158?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2016-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02719158?
The interventions under investigation include: Sham (OTHER), 12 mg ciprofloxacin (DRUG), 6 mg ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT02719158?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.